December 03, 2020
BioPharmGuy News
Collaborate with Pfizer CentreOne and access the regulatory and technical expertise used by Pfizer to develop and launch APIs and drug products in multiple markets.

Visit the Pfizer CentreOne website for more information.
BioPharmGuy
Just an FYI for anyone who may have contacted us in the past - we are in the process of transitioning email accounts to our bpg.bio domain. We will still check the biopharmguy.com email addresses but maybe not as often.

Addition & Attrition
Busy this weekend. 26 companies added, four removed. Summary file on our downloads page.
Industry
Y-Mabs
The impossible has finally happened - one of the five US-based drug companies we list whose name starts with the letter Y officially has an approved product! Y-Mabs got the greenlight for a subset population of pediatric neuroblastoma patients. 

Our alphabet is now complete - here are the numbers: 
Chart of Company Names
CURE Pharmaceutical
With a name like this, you'd better believe they have big dreams. And those dreams involve marijuana and the little-blue-pill-whose-name-starts-with-V-but-if-we-drop-that-name-this-email-will-get-flagged-as-spam.

Sounds like a fun night, but those aren't cures, just treatments. Typical.

Kyorin
Their pipeline page would have you know that: All of the products we offer carry with them our wish for a "smiley society." 

Translation error? Maybe, but we prefer to believe this is just an upbeat-as-hell place to work.

Nihon Pharmaceutical
Then we have Nihon Pharmaceutical whose home page states they are: Continuing to protect irreplaceable "Lives". 

Not sure what the quotes around Lives is meant to indicate. Maybe they only have drugs for robots.

Kinaset Therapeutics
New company launched in Boston this week with a cool $40M. Their sole asset is a previously developed molecule they acquired which was formerly known as VR588. Kinaset decided to re-name it KN-002. Look at those sly devils acting like there was ever a KN-001. Lies!

Hopefully all you eosinophilic and non-eosinophilic severe asthma patients out there will get some good news on KN-0021 in a few years.

ALR Technologies
On their most recent 10-Q quarterly report, these guys show $708 in assets despite having a market capitalization of $34M. (They had $596 in assets same time last year, so, hey, up 19%!)

Lines of credit seem to be funding the entire operation. They also appear to be paying 1% per month on a lot of their debt. Seems like a ridiculous rate...ohhhhh wait a minute. There it is. The CEO and his wife have loaned the company $23M of their personal fortune at 1% interest per month. 

Milking a cool $2.75M off the company each year in addition to the $240k salary? No conflict of interest to see here. No way would the CEO prioritize paying himself back over moving the business forward.

Maybe an app that pretty much just send texts to your doctor isn't the money spinner they had hoped.
Health & Science
Vaccine
The United Kingdom became the first country to give the Pfizer/BioNTech Covid vaccine an emergency approval. Russia & China had both previously approved domestically-produced vaccines, but on the back of almost no clinical data. This is the first approval of a Covid vaccine with a reasonable amount of clinical data supporting it.

The UK has purchased 20 million vaccine courses. Pfizer's plant in Belgium will be producing vaccine for the European market - some of which have already shipped. Stateside we can expect doses to arrive around the country from the Kalamazoo, MI plant by mid-December and be ready to go as soon as approval comes.

BioCalendar
One of our favorite newsletters, Big4Bio, has launched a new BioCalendar. It's a simple calendar of biotech conferences/events/etc. Simple resources are often the best. Looks pretty cheap to get your event listed too.

Reviews Don't Stink
Who knew candles would be pandemic losers?

Per Twitter user's @kate_ptrv analysis, the average ratings for the top three scented and unscented candles on Amazon have both dropped throughout the year. However the scented candles' ratings have dropped more.

Why? Likely because people are losing their sense of smell and complaining that the candles have no scent. The proportion of reviews that mention a lack of scent has reached new heights in October/November 2020. Not a good omen.

#Obvious
If you're like the rest of us, you can't believe you didn't think of the idea of encapsulating mRNA instructions for spike protein in lipid nanoparticles first. 
Etc.
Air "Fryers"
Though there's no frying involved, people really love their air fryers. Just like they used to love their Foreman grills. 

If you don't know, 'air fryer' is a marketing term for a convection toaster oven. To that end, Wirecutter reviewed products labeled as air fryers and convection toaster ovens and concluded none of the products labeled as air fryers were the best air fryer. 

Wake up to Big Kitchen's lies!
Subscribe
If you were forwarded this email and would like to join our mailing list, here's our sign-up page: https://biopharmguy.com/subscribe.php
Premium Listings Always Available
Promote your Company's Listing
Check your website analytics - we are likely one of your top referrers. You can quickly double those referrals with a Premium Listing. Try it for as short as one month. Full summary of all our upgrade options available here: Promoted Listings. Reply to this email or send a message if interested.